Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

CohBar, Inc. CWBR NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

CohBar, Inc. (CWBR) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 5 Buy.

CWBR Analyst Ratings

Buy
5
Ratings
5 Buy
Based on 5 analysts giving stock ratings to CohBar, Inc. in the past 3 months
Rating breakdown
Buy
5 100%
100%
Buy
5 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

People Also View

ZURA
ZURA
Zura Bio Limited
$5.72
+0.70%
 ELEV
ELEV
Elevation Oncology, Inc.
$0.37
-2.12%
 AVRO
AVRO
AVROBIO, Inc.
$1.40
-1.41%
 ENVB
ENVB
Enveric Biosciences, Inc.
$1.95
-1.02%
 HEPA
HEPA
Hepion Pharmaceuticals, Inc.
$0.05
+18.52%
 OCEA
OCEA
Ocean Biomedical, Inc.
$0.00
+0.00%
 EFTR
EFTR
eFFECTOR Therapeutics, Inc.
$0.00
+0.00%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message